Alle Storys
Folgen
Keine Story von ARTTIC Innovation GmbH mehr verpassen.

ARTTIC Innovation GmbH

LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision

LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
  • Bild-Infos
  • Download

Ein Dokument

CanSERV Second Open Call Still Open

canSERV Invites Cancer Researchers to Apply for Free State of the Art Research Services and Training in a Second Open Call for Service Provision

European life science infrastructures offer academia and industry free of charge access to cutting-edge cancer research services to address the needs of the entire oncological research pipeline.

To tackle the challenges of cancer and address Europe’s Cancer Mission and Beating Cancer Plan, the EU-funded project canSERV offers more than 400 innovative cancer research technologies to European and non-European cancer researchers at all levels. The service, or a combination of services and training, can be requested to accelerate ground-breaking discoveries and their translation into clinical applications.

canSERV promotes the development of concrete solutions for cancer by providing a comprehensive set of world-class oncology technologies and state of the art training to cancer scientists.  

canSERV Enables Researchers to Cover the Entire Range of the Oncology Developmental Pipeline      

Continuing the success of the project’s first Open Call for Service Provision, canSERV once again invites applications covering the entire range of the oncology developmental pipeline; supporting discoveries in fundamental research to translational science and personalised oncology.  

canSERV welcomes excellent research applications addressing at least one of the four strategic goals of Europe’s Cancer Mission: 

  1. Understanding of Cancer 
  2. Prevention and Early Detection 
  3. Diagnosis and treatment 
  4. Quality of life for patients and their families 

Researchers from academia, industry and SMEs may apply for several services including: i) disease models, ii) cutting-edge imaging and structural biology technologies, iii) biomarker research and development, iv) new therapeutic solutions, v) complex clinical trial design and support, vi) personalised oncology implementation pipelines and recommendations and vii) regulatory support and tools to analyse the socioeconomic dimension of research activities.  

Launch of the call: 27 February 2024.  

Submission deadline: 21 May 2024, 2pm CEST. 

The applications will be reviewed by an international, independent review panel!

The tentative budget for this first call is 1.0 Mio. EURO. For more information and the call text, please visit our CanSERV project website:  www.canSERV.eu/Calls. For guidance on making a successful application, watch the canSERV Open Call webinar.

Further information:  

canSERV website:  www.canserv.eu   

Twitter:  @canSERV_EU  

LinkedIn:  canSERV  

Project coordination, BBMRI-ERIC:  

Prof. Jens K. Habermann, Director General  

Judit Balogh, Senior Project Manager  

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.

The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.

ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development. For more information, please visit www.arttic-innovation.de.

We take your privacy seriously. Click here to read our privacy policy. If you no longer wish to receive emails from us, please click below.